Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.

Guo CC, Wang Y, Xiao L, Troncoso P, Czerniak BA.

Hum Pathol. 2012 May;43(5):644-9. doi: 10.1016/j.humpath.2011.06.018. Epub 2011 Sep 19.

PMID:
21937078
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[TMPRSS2-ERG gene fusion in metastatic prostate cancers: a study of fine needle aspiration specimens].

Xiao L, Zhu XZ, Wang Y, Gong Y, Guo CC.

Zhonghua Bing Li Xue Za Zhi. 2011 Jun;40(6):392-6. Chinese.

PMID:
21914348
[PubMed - indexed for MEDLINE]
3.

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.

Yoshimoto M, Ding K, Sweet JM, Ludkovski O, Trottier G, Song KS, Joshua AM, Fleshner NE, Squire JA, Evans AJ.

Mod Pathol. 2013 Mar;26(3):435-47. doi: 10.1038/modpathol.2012.162. Epub 2012 Sep 28.

PMID:
23018874
[PubMed - indexed for MEDLINE]
Free Article
4.

ERG rearrangement is present in a subset of transition zone prostatic tumors.

Falzarano SM, Navas M, Simmerman K, Klein EA, Rubin MA, Zhou M, Magi-Galluzzi C.

Mod Pathol. 2010 Nov;23(11):1499-506. doi: 10.1038/modpathol.2010.150. Epub 2010 Aug 6.

PMID:
20693982
[PubMed - indexed for MEDLINE]
Free Article
5.

Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion.

Guo CC, Zuo G, Cao D, Troncoso P, Czerniak BA.

Mod Pathol. 2009 Jul;22(7):866-71. doi: 10.1038/modpathol.2009.57. Epub 2009 Apr 24.

PMID:
19396154
[PubMed - indexed for MEDLINE]
Free Article
6.

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome.

Yoshimoto M, Joshua AM, Cunha IW, Coudry RA, Fonseca FP, Ludkovski O, Zielenska M, Soares FA, Squire JA.

Mod Pathol. 2008 Dec;21(12):1451-60. doi: 10.1038/modpathol.2008.96. Epub 2008 May 23.

PMID:
18500259
[PubMed - indexed for MEDLINE]
Free Article
7.

ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples.

Miyagi Y, Sasaki T, Fujinami K, Sano J, Senga Y, Miura T, Kameda Y, Sakuma Y, Nakamura Y, Harada M, Tsuchiya E.

Mod Pathol. 2010 Nov;23(11):1492-8. doi: 10.1038/modpathol.2010.149. Epub 2010 Aug 6.

PMID:
20693979
[PubMed - indexed for MEDLINE]
Free Article
8.

ERG rearrangement metastasis patterns in locally advanced prostate cancer.

Perner S, Svensson MA, Hossain RR, Day JR, Groskopf J, Slaughter RC, Jarleborn AR, Hofer MD, Kuefer R, Demichelis F, Rickman DS, Rubin MA.

Urology. 2010 Apr;75(4):762-7. doi: 10.1016/j.urology.2009.10.010.

PMID:
20018353
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.

Fine SW, Gopalan A, Leversha MA, Al-Ahmadie HA, Tickoo SK, Zhou Q, Satagopan JM, Scardino PT, Gerald WL, Reuter VE.

Mod Pathol. 2010 Oct;23(10):1325-33. doi: 10.1038/modpathol.2010.120. Epub 2010 Jun 18.

PMID:
20562851
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.

Furusato B, Gao CL, Ravindranath L, Chen Y, Cullen J, McLeod DG, Dobi A, Srivastava S, Petrovics G, Sesterhenn IA.

Mod Pathol. 2008 Feb;21(2):67-75. Epub 2007 Dec 7.

PMID:
18065961
[PubMed - indexed for MEDLINE]
Free Article
11.

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort.

Esgueva R, Perner S, J LaFargue C, Scheble V, Stephan C, Lein M, Fritzsche FR, Dietel M, Kristiansen G, Rubin MA.

Mod Pathol. 2010 Apr;23(4):539-46. doi: 10.1038/modpathol.2009.193. Epub 2010 Jan 29.

PMID:
20118910
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.

Toubaji A, Albadine R, Meeker AK, Isaacs WB, Lotan T, Haffner MC, Chaux A, Epstein JI, Han M, Walsh PC, Partin AW, De Marzo AM, Platz EA, Netto GJ.

Mod Pathol. 2011 Nov;24(11):1511-20. doi: 10.1038/modpathol.2011.111. Epub 2011 Jul 8.

PMID:
21743434
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.

Saramäki OR, Harjula AE, Martikainen PM, Vessella RL, Tammela TL, Visakorpi T.

Clin Cancer Res. 2008 Jun 1;14(11):3395-400. doi: 10.1158/1078-0432.CCR-07-2051.

PMID:
18519769
[PubMed - indexed for MEDLINE]
Free Article
14.

Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy.

Rubio-Briones J, Fernández-Serra A, Calatrava A, García-Casado Z, Rubio L, Bonillo MA, Iborra I, Solsona E, López-Guerrero JA.

J Urol. 2010 May;183(5):2054-61. doi: 10.1016/j.juro.2009.12.096. Epub 2010 Mar 19.

PMID:
20303538
[PubMed - indexed for MEDLINE]
15.

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.

Mosquera JM, Mehra R, Regan MM, Perner S, Genega EM, Bueti G, Shah RB, Gaston S, Tomlins SA, Wei JT, Kearney MC, Johnson LA, Tang JM, Chinnaiyan AM, Rubin MA, Sanda MG.

Clin Cancer Res. 2009 Jul 15;15(14):4706-11. doi: 10.1158/1078-0432.CCR-08-2927. Epub 2009 Jul 7.

PMID:
19584163
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.

Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW, Eastham JA, Scardino PT, Scher HI, Tickoo SK, Reuter VE, Gerald WL.

Cancer Res. 2009 Feb 15;69(4):1400-6. doi: 10.1158/0008-5472.CAN-08-2467. Epub 2009 Feb 3.

PMID:
19190343
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.

FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME, Ostrander EA, Stanford JL, Huntsman DG.

BMC Cancer. 2008 Aug 11;8:230. doi: 10.1186/1471-2407-8-230.

PMID:
18694509
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.

Albadine R, Latour M, Toubaji A, Haffner M, Isaacs WB, A Platz E, Meeker AK, Demarzo AM, Epstein JI, Netto GJ.

Mod Pathol. 2009 Nov;22(11):1415-22. doi: 10.1038/modpathol.2009.121. Epub 2009 Sep 4.

PMID:
19734849
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.

Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, Osunkoya AO, MacLennan GT, Montironi R, Cheng L.

Mod Pathol. 2011 Aug;24(8):1120-7. doi: 10.1038/modpathol.2011.56. Epub 2011 Apr 15.

PMID:
21499238
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort.

Darnel AD, Lafargue CJ, Vollmer RT, Corcos J, Bismar TA.

Cancer Biol Ther. 2009 Jan;8(2):125-30. Epub 2009 Feb 4.

PMID:
19029822
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk